nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—hypertension—focal segmental glomerulosclerosis	0.528	1	CtDrD
Verapamil—ABCC10—Cyclosporine—focal segmental glomerulosclerosis	0.077	0.205	CbGbCtD
Verapamil—ABCC3—Cyclosporine—focal segmental glomerulosclerosis	0.0484	0.129	CbGbCtD
Verapamil—ABCB11—Cyclosporine—focal segmental glomerulosclerosis	0.0419	0.111	CbGbCtD
Verapamil—ABCC1—Cyclosporine—focal segmental glomerulosclerosis	0.0297	0.079	CbGbCtD
Verapamil—SLCO1A2—Cyclosporine—focal segmental glomerulosclerosis	0.0266	0.0706	CbGbCtD
Verapamil—SLCO1B1—Cyclosporine—focal segmental glomerulosclerosis	0.0251	0.0666	CbGbCtD
Verapamil—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.022	0.0585	CbGbCtD
Verapamil—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.0199	0.0529	CbGbCtD
Verapamil—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.0147	0.0391	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.0147	0.0391	CbGbCtD
Verapamil—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.011	0.0293	CbGbCtD
Verapamil—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0282	CbGbCtD
Verapamil—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.00889	0.0236	CbGbCtD
Verapamil—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.00739	0.0197	CbGbCtD
Verapamil—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.00718	0.0191	CbGbCtD
Verapamil—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.00676	0.018	CbGbCtD
Verapamil—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0114	CbGbCtD
Verapamil—Gingival hyperplasia—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.0991	CcSEcCtD
Verapamil—Hyperkeratosis—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.0934	CcSEcCtD
Verapamil—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.000605	0.0351	CcSEcCtD
Verapamil—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.000595	0.0346	CcSEcCtD
Verapamil—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.000473	0.0567	CbGeAlD
Verapamil—CACNB2—cortex of kidney—focal segmental glomerulosclerosis	0.000422	0.0506	CbGeAlD
Verapamil—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.000411	0.0239	CcSEcCtD
Verapamil—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.000405	0.0485	CbGeAlD
Verapamil—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000373	0.0217	CcSEcCtD
Verapamil—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.000363	0.0211	CcSEcCtD
Verapamil—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000346	0.0201	CcSEcCtD
Verapamil—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.000342	0.0199	CcSEcCtD
Verapamil—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00034	0.0198	CcSEcCtD
Verapamil—SLC22A4—nephron tubule—focal segmental glomerulosclerosis	0.000339	0.0406	CbGeAlD
Verapamil—SLCO1B1—kidney—focal segmental glomerulosclerosis	0.000335	0.0402	CbGeAlD
Verapamil—ABCC3—kidney—focal segmental glomerulosclerosis	0.000318	0.0381	CbGeAlD
Verapamil—ABCC10—kidney—focal segmental glomerulosclerosis	0.000317	0.038	CbGeAlD
Verapamil—ABCC10—cortex of kidney—focal segmental glomerulosclerosis	0.000308	0.037	CbGeAlD
Verapamil—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.0003	0.0174	CcSEcCtD
Verapamil—ABCC4—nephron tubule—focal segmental glomerulosclerosis	0.000299	0.0358	CbGeAlD
Verapamil—SLC22A4—kidney—focal segmental glomerulosclerosis	0.000298	0.0357	CbGeAlD
Verapamil—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000294	0.0171	CcSEcCtD
Verapamil—SLC22A4—cortex of kidney—focal segmental glomerulosclerosis	0.00029	0.0347	CbGeAlD
Verapamil—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.000289	0.0347	CbGeAlD
Verapamil—SLC22A1—kidney—focal segmental glomerulosclerosis	0.000284	0.034	CbGeAlD
Verapamil—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000283	0.0165	CcSEcCtD
Verapamil—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000281	0.0163	CcSEcCtD
Verapamil—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000276	0.0161	CcSEcCtD
Verapamil—SLCO1A2—kidney—focal segmental glomerulosclerosis	0.000273	0.0327	CbGeAlD
Verapamil—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000268	0.0156	CcSEcCtD
Verapamil—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000266	0.0155	CcSEcCtD
Verapamil—ABCC4—kidney—focal segmental glomerulosclerosis	0.000263	0.0315	CbGeAlD
Verapamil—ABCC4—cortex of kidney—focal segmental glomerulosclerosis	0.000256	0.0307	CbGeAlD
Verapamil—ABCC2—kidney—focal segmental glomerulosclerosis	0.000254	0.0305	CbGeAlD
Verapamil—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000253	0.0147	CcSEcCtD
Verapamil—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000252	0.0146	CcSEcCtD
Verapamil—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00025	0.0146	CcSEcCtD
Verapamil—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.000248	0.0297	CbGeAlD
Verapamil—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000241	0.014	CcSEcCtD
Verapamil—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000231	0.0134	CcSEcCtD
Verapamil—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000231	0.0134	CcSEcCtD
Verapamil—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.0133	CcSEcCtD
Verapamil—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.0133	CcSEcCtD
Verapamil—SLC22A5—nephron tubule—focal segmental glomerulosclerosis	0.000224	0.0269	CbGeAlD
Verapamil—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000222	0.0129	CcSEcCtD
Verapamil—ABCC1—cortex of kidney—focal segmental glomerulosclerosis	0.000218	0.0261	CbGeAlD
Verapamil—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000215	0.0125	CcSEcCtD
Verapamil—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000214	0.0124	CcSEcCtD
Verapamil—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.000211	0.0253	CbGeAlD
Verapamil—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.0118	CcSEcCtD
Verapamil—SLC22A5—kidney—focal segmental glomerulosclerosis	0.000197	0.0236	CbGeAlD
Verapamil—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.000196	0.0235	CbGeAlD
Verapamil—CYP2B6—nephron tubule—focal segmental glomerulosclerosis	0.000195	0.0233	CbGeAlD
Verapamil—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.0112	CcSEcCtD
Verapamil—SLC22A5—cortex of kidney—focal segmental glomerulosclerosis	0.000192	0.023	CbGeAlD
Verapamil—CYP2C8—kidney—focal segmental glomerulosclerosis	0.000191	0.0229	CbGeAlD
Verapamil—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000189	0.011	CcSEcCtD
Verapamil—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000188	0.0109	CcSEcCtD
Verapamil—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000184	0.0107	CcSEcCtD
Verapamil—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000183	0.0107	CcSEcCtD
Verapamil—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00018	0.0105	CcSEcCtD
Verapamil—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000174	0.0101	CcSEcCtD
Verapamil—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000173	0.0101	CcSEcCtD
Verapamil—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000172	0.0206	CbGeAlD
Verapamil—CYP2B6—kidney—focal segmental glomerulosclerosis	0.000171	0.0205	CbGeAlD
Verapamil—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000171	0.00993	CcSEcCtD
Verapamil—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000171	0.00993	CcSEcCtD
Verapamil—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000171	0.00993	CcSEcCtD
Verapamil—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000169	0.00981	CcSEcCtD
Verapamil—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000168	0.0201	CbGeAlD
Verapamil—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.00971	CcSEcCtD
Verapamil—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000165	0.0096	CcSEcCtD
Verapamil—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000164	0.00952	CcSEcCtD
Verapamil—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000164	0.00952	CcSEcCtD
Verapamil—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000163	0.00946	CcSEcCtD
Verapamil—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000158	0.0092	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000149	0.00868	CcSEcCtD
Verapamil—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000148	0.00861	CcSEcCtD
Verapamil—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.00855	CcSEcCtD
Verapamil—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.00849	CcSEcCtD
Verapamil—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.00846	CcSEcCtD
Verapamil—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000144	0.00838	CcSEcCtD
Verapamil—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000141	0.00821	CcSEcCtD
Verapamil—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00014	0.00814	CcSEcCtD
Verapamil—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00014	0.00814	CcSEcCtD
Verapamil—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000135	0.00785	CcSEcCtD
Verapamil—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00013	0.00756	CcSEcCtD
Verapamil—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000129	0.0155	CbGeAlD
Verapamil—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000127	0.0152	CbGeAlD
Verapamil—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000121	0.00702	CcSEcCtD
Verapamil—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000118	0.00683	CcSEcCtD
Verapamil—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000116	0.00674	CcSEcCtD
Verapamil—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000112	0.00651	CcSEcCtD
Verapamil—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000108	0.0063	CcSEcCtD
Verapamil—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000104	0.00605	CcSEcCtD
Verapamil—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000104	0.0125	CbGeAlD
Verapamil—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000103	0.006	CcSEcCtD
Verapamil—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000103	0.006	CcSEcCtD
Verapamil—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000103	0.00597	CcSEcCtD
Verapamil—Nausea—Cyclosporine—focal segmental glomerulosclerosis	9.73e-05	0.00566	CcSEcCtD
Verapamil—ABCB1—kidney—focal segmental glomerulosclerosis	9.15e-05	0.011	CbGeAlD
Verapamil—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	8.91e-05	0.0107	CbGeAlD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.28e-05	0.000325	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	2.27e-05	0.000323	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—LPL—focal segmental glomerulosclerosis	2.24e-05	0.000319	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.23e-05	0.000318	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—LPL—focal segmental glomerulosclerosis	2.22e-05	0.000316	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—MMP9—focal segmental glomerulosclerosis	2.2e-05	0.000313	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—MMP9—focal segmental glomerulosclerosis	2.2e-05	0.000313	CbGpPWpGaD
Verapamil—ABCC3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	2.19e-05	0.000312	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.17e-05	0.000309	CbGpPWpGaD
Verapamil—SLC6A4—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	2.15e-05	0.000307	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—MMP9—focal segmental glomerulosclerosis	2.14e-05	0.000305	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	2.13e-05	0.000304	CbGpPWpGaD
Verapamil—ABCC2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.13e-05	0.000303	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—MMP2—focal segmental glomerulosclerosis	2.11e-05	0.0003	CbGpPWpGaD
Verapamil—ABCC1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.1e-05	0.0003	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—MMP2—focal segmental glomerulosclerosis	2.08e-05	0.000297	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—MMP2—focal segmental glomerulosclerosis	2.08e-05	0.000297	CbGpPWpGaD
Verapamil—ABCC4—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	2.06e-05	0.000293	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.01e-05	0.000286	CbGpPWpGaD
Verapamil—SLCO1B1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2e-05	0.000285	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.91e-05	0.000272	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—MMP9—focal segmental glomerulosclerosis	1.91e-05	0.000272	CbGpPWpGaD
Verapamil—SLCO1A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	1.9e-05	0.000271	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—MMP9—focal segmental glomerulosclerosis	1.88e-05	0.000268	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.85e-05	0.000264	CbGpPWpGaD
Verapamil—ABCG2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.85e-05	0.000264	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—MMP9—focal segmental glomerulosclerosis	1.85e-05	0.000263	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—LPL—focal segmental glomerulosclerosis	1.85e-05	0.000263	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.81e-05	0.000258	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—MMP2—focal segmental glomerulosclerosis	1.79e-05	0.000255	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—MMP9—focal segmental glomerulosclerosis	1.78e-05	0.000254	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.78e-05	0.000253	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.76e-05	0.000251	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.74e-05	0.000248	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—LPL—focal segmental glomerulosclerosis	1.74e-05	0.000247	CbGpPWpGaD
Verapamil—ABCC2—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	1.74e-05	0.000247	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.71e-05	0.000243	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—MMP2—focal segmental glomerulosclerosis	1.69e-05	0.000241	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—LIPC—focal segmental glomerulosclerosis	1.66e-05	0.000236	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—LIPC—focal segmental glomerulosclerosis	1.65e-05	0.000234	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	1.64e-05	0.000234	CbGpPWpGaD
Verapamil—SLCO1B1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	1.62e-05	0.000231	CbGpPWpGaD
Verapamil—SLC22A4—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.6e-05	0.000228	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.58e-05	0.000226	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—MMP9—focal segmental glomerulosclerosis	1.58e-05	0.000226	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—AGT—focal segmental glomerulosclerosis	1.58e-05	0.000225	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.57e-05	0.000224	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—MMP9—focal segmental glomerulosclerosis	1.57e-05	0.000223	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—MMP9—focal segmental glomerulosclerosis	1.57e-05	0.000223	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.55e-05	0.00022	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.53e-05	0.000218	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.52e-05	0.000217	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.52e-05	0.000216	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	1.5e-05	0.000214	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—MMP2—focal segmental glomerulosclerosis	1.49e-05	0.000212	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—AGT—focal segmental glomerulosclerosis	1.49e-05	0.000212	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	1.48e-05	0.00021	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	1.47e-05	0.00021	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—CTGF—focal segmental glomerulosclerosis	1.46e-05	0.000208	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—FN1—focal segmental glomerulosclerosis	1.45e-05	0.000206	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—CTGF—focal segmental glomerulosclerosis	1.45e-05	0.000206	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—LIPC—focal segmental glomerulosclerosis	1.45e-05	0.000206	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—NOS2—focal segmental glomerulosclerosis	1.43e-05	0.000204	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.41e-05	0.000201	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.39e-05	0.000198	CbGpPWpGaD
Verapamil—SLC22A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	1.39e-05	0.000198	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—LIPC—focal segmental glomerulosclerosis	1.35e-05	0.000193	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.34e-05	0.000192	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—MMP9—focal segmental glomerulosclerosis	1.34e-05	0.000191	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.33e-05	0.00019	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1.33e-05	0.00019	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—LIPC—focal segmental glomerulosclerosis	1.33e-05	0.00019	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.32e-05	0.000188	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.32e-05	0.000188	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—LIPC—focal segmental glomerulosclerosis	1.3e-05	0.000185	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.29e-05	0.000184	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—CTGF—focal segmental glomerulosclerosis	1.27e-05	0.000181	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—MMP9—focal segmental glomerulosclerosis	1.27e-05	0.000181	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.24e-05	0.000177	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.22e-05	0.000173	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—ALB—focal segmental glomerulosclerosis	1.21e-05	0.000173	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.21e-05	0.000172	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—ALB—focal segmental glomerulosclerosis	1.2e-05	0.000171	CbGpPWpGaD
Verapamil—SLC22A5—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.2e-05	0.000171	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.19e-05	0.00017	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—CTGF—focal segmental glomerulosclerosis	1.19e-05	0.00017	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.17e-05	0.000167	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—CTGF—focal segmental glomerulosclerosis	1.17e-05	0.000167	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.17e-05	0.000166	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CTGF—focal segmental glomerulosclerosis	1.14e-05	0.000163	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—ALB—focal segmental glomerulosclerosis	1.14e-05	0.000162	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.13e-05	0.000161	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	1.13e-05	0.000161	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.13e-05	0.000161	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—MMP9—focal segmental glomerulosclerosis	1.12e-05	0.000159	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.11e-05	0.000158	CbGpPWpGaD
Verapamil—ABCC3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.11e-05	0.000158	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.11e-05	0.000158	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.1e-05	0.000156	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.1e-05	0.000156	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.08e-05	0.000154	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—LPL—focal segmental glomerulosclerosis	1.06e-05	0.000151	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.05e-05	0.00015	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.05e-05	0.000149	CbGpPWpGaD
Verapamil—ABCC4—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.04e-05	0.000148	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.02e-05	0.000145	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.01e-05	0.000145	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.01e-05	0.000144	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—LPL—focal segmental glomerulosclerosis	1.01e-05	0.000144	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—LPL—focal segmental glomerulosclerosis	1e-05	0.000143	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1e-05	0.000143	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	9.93e-06	0.000142	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	9.78e-06	0.000139	CbGpPWpGaD
Verapamil—SLCO1A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	9.65e-06	0.000137	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—LIPC—focal segmental glomerulosclerosis	9.65e-06	0.000137	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	9.31e-06	0.000133	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	9.21e-06	0.000131	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.15e-06	0.00013	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	9.13e-06	0.00013	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AGT—focal segmental glomerulosclerosis	9.07e-06	0.000129	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CTGF—focal segmental glomerulosclerosis	8.94e-06	0.000127	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—LIPC—focal segmental glomerulosclerosis	8.93e-06	0.000127	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	8.92e-06	0.000127	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	8.85e-06	0.000126	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—LPL—focal segmental glomerulosclerosis	8.82e-06	0.000126	CbGpPWpGaD
Verapamil—ABCC2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	8.79e-06	0.000125	CbGpPWpGaD
Verapamil—ABCC1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	8.68e-06	0.000124	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	8.68e-06	0.000124	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	8.66e-06	0.000123	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AGT—focal segmental glomerulosclerosis	8.65e-06	0.000123	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AGT—focal segmental glomerulosclerosis	8.59e-06	0.000122	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CTGF—focal segmental glomerulosclerosis	8.49e-06	0.000121	CbGpPWpGaD
Verapamil—SLCO1B1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	8.25e-06	0.000118	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—LPL—focal segmental glomerulosclerosis	8.25e-06	0.000117	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—LIPC—focal segmental glomerulosclerosis	8.24e-06	0.000117	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.23e-06	0.000117	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—LPL—focal segmental glomerulosclerosis	8.13e-06	0.000116	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—LPL—focal segmental glomerulosclerosis	7.91e-06	0.000113	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	7.86e-06	0.000112	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.83e-06	0.000112	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	7.8e-06	0.000111	CbGpPWpGaD
Verapamil—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.64e-06	0.000109	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	7.62e-06	0.000109	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TGFB1—focal segmental glomerulosclerosis	7.61e-06	0.000108	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.6e-06	0.000108	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AGT—focal segmental glomerulosclerosis	7.55e-06	0.000108	CbGpPWpGaD
Verapamil—ABCC1—Disease—LPL—focal segmental glomerulosclerosis	7.4e-06	0.000105	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CTGF—focal segmental glomerulosclerosis	7.25e-06	0.000103	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.25e-06	0.000103	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.18e-06	0.000102	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AGT—focal segmental glomerulosclerosis	7.06e-06	0.000101	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.05e-06	0.0001	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—ALB—focal segmental glomerulosclerosis	6.96e-06	9.92e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AGT—focal segmental glomerulosclerosis	6.95e-06	9.91e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—LPL—focal segmental glomerulosclerosis	6.88e-06	9.81e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.78e-06	9.66e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AGT—focal segmental glomerulosclerosis	6.76e-06	9.64e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.68e-06	9.52e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—ALB—focal segmental glomerulosclerosis	6.64e-06	9.46e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—ALB—focal segmental glomerulosclerosis	6.59e-06	9.39e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	6.58e-06	9.38e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—LIPC—focal segmental glomerulosclerosis	6.55e-06	9.33e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.5e-06	9.26e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	6.4e-06	9.12e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—LPL—focal segmental glomerulosclerosis	6.2e-06	8.83e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.18e-06	8.81e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AGT—focal segmental glomerulosclerosis	5.89e-06	8.39e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—LPL—focal segmental glomerulosclerosis	5.89e-06	8.39e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.8e-06	8.26e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ALB—focal segmental glomerulosclerosis	5.79e-06	8.25e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—NOS2—focal segmental glomerulosclerosis	5.78e-06	8.23e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CTGF—focal segmental glomerulosclerosis	5.77e-06	8.21e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	5.63e-06	8.03e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	5.54e-06	7.9e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	5.45e-06	7.77e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ALB—focal segmental glomerulosclerosis	5.41e-06	7.71e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	5.4e-06	7.7e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ALB—focal segmental glomerulosclerosis	5.34e-06	7.6e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.31e-06	7.57e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AGT—focal segmental glomerulosclerosis	5.3e-06	7.55e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.29e-06	7.54e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.28e-06	7.53e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.19e-06	7.4e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ALB—focal segmental glomerulosclerosis	5.19e-06	7.4e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AGT—focal segmental glomerulosclerosis	5.04e-06	7.18e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—LPL—focal segmental glomerulosclerosis	5.03e-06	7.16e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.99e-06	7.11e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	4.95e-06	7.05e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	4.88e-06	6.95e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—SERPINE1—focal segmental glomerulosclerosis	4.87e-06	6.93e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	4.83e-06	6.88e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	4.66e-06	6.64e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	4.62e-06	6.59e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	4.55e-06	6.48e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ALB—focal segmental glomerulosclerosis	4.52e-06	6.44e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.52e-06	6.44e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	4.51e-06	6.43e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.5e-06	6.41e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.45e-06	6.34e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	4.36e-06	6.21e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AGT—focal segmental glomerulosclerosis	4.3e-06	6.13e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.25e-06	6.06e-05	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.13e-06	5.89e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ALB—focal segmental glomerulosclerosis	4.07e-06	5.79e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.06e-06	5.78e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.01e-06	5.72e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	4.01e-06	5.71e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—LPL—focal segmental glomerulosclerosis	4e-06	5.69e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	3.97e-06	5.66e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.92e-06	5.58e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	3.91e-06	5.57e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ALB—focal segmental glomerulosclerosis	3.87e-06	5.51e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	3.86e-06	5.49e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.69e-06	5.26e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.66e-06	5.21e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	3.58e-06	5.1e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	3.55e-06	5.05e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.47e-06	4.94e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AGT—focal segmental glomerulosclerosis	3.42e-06	4.87e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	3.39e-06	4.84e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	3.38e-06	4.82e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	3.34e-06	4.76e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ALB—focal segmental glomerulosclerosis	3.3e-06	4.7e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.13e-06	4.46e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—TGFB1—focal segmental glomerulosclerosis	3.07e-06	4.38e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	3.02e-06	4.3e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	2.98e-06	4.24e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	2.95e-06	4.2e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	2.89e-06	4.12e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	2.78e-06	3.96e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	2.75e-06	3.92e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ALB—focal segmental glomerulosclerosis	2.62e-06	3.74e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	2.62e-06	3.73e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	2.58e-06	3.68e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	2.56e-06	3.65e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	2.52e-06	3.59e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.41e-06	3.44e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	2.38e-06	3.39e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	2.36e-06	3.36e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	2.35e-06	3.35e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	2.22e-06	3.16e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	2.01e-06	2.87e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	1.98e-06	2.82e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	1.93e-06	2.76e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1.82e-06	2.6e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.82e-06	2.59e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.81e-06	2.58e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.55e-06	2.21e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.54e-06	2.2e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.19e-06	1.7e-05	CbGpPWpGaD
